Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adoption and Early Implementation Evaluation of a Heart Failure Nursing Protocol in Veterans Health Clinics.

Journal of nursing care quality·2026
Same author

Impact of the Veterans Affairs National Telestroke Program's Subacute Telestroke Service on Interhospital Transfers.

The Neurohospitalist·2025
Same author

Editorial: Using the RE-AIM framework and other implementation theories, models, and frameworks to guide the implementation and evaluation of rural health innovations.

Frontiers in health services·2025
Same author

Feasibility of Conducting Real-Time Qualitative Interviews With Emergency Department Patients: Lessons From Lung Cancer Screening Research.

Annals of emergency medicine·2025
Same author

Clinician Perspectives on Barriers and Facilitators to Providing Medications for Opioid Use Disorder for Adolescents.

Journal of addiction medicine·2025
Same author

Feasibility and acceptability of a telephone-based ACT intervention for caregivers (TACTICs) of adults with Alzheimer's disease and related dementias (ADRD): a randomized pilot during the COVID-19 pandemic.

Aging & mental health·2025

相关实验视频

Updated: Jul 11, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K

在多个临床环境中实施药物基因组学:定性评估.

Sarah A Shue1, Elizabeth Rowe2, Lauren A Bell2

  • 1VA HSR&D Center for Health Information & Communication, Roudebush VA Medical Center, Indianapolis, IN 46202, USA.

Pharmacogenomics
|November 17, 2023
PubMed
概括

实施药物基因组学 (PGx) 测试面临着诸如不清楚的付款和工作流的问题等挑战. 然而,强大的领导力和多学科团队可以促进其在临床环境中成功采用.

关键词:
在CFIR中,CFIR是最重要的.通过通过通过通过.障碍物 障碍物 障碍物促进者是指促进者.药物遗传学测试 药物遗传学测试 药物遗传学测试

更多相关视频

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

相关实验视频

Last Updated: Jul 11, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

科学领域:

  • 临床实施科学 临床实施科学
  • 基因组医学是一种基因组医学.

背景情况:

  • 药物基因组学 (PGx) 测试的临床采用对于个性化医学至关重要.
  • 了解实施障碍和促进者是推动PGx使用的关键.

研究的目的:

  • 识别和检查阻碍和促进PGx计划积极实施的障碍和促进因素.
  • 收集来自学术医疗保健系统内的各种贡献者的见解.

主要方法:

  • 与参与PGx实施的28名贡献者进行了定性访谈.
  • 参与者包括临床提供者和信息学专家.

主要成果:

  • 发现的关键障碍包括不清楚的支付机制,决策支持工具的开发,严格的工作流程和提供者教育.
  • 一个多学科的实施团队和领导支持被认为是重要的促进者.
  • 参与者提出了解决发现障碍的策略,并利用促进者.

结论:

  • 实施贡献者的现实世界感知为PGx实施提供了一个全面的框架.
  • 结果可以为最佳实践指南提供信息,以加强PGx在医疗保健系统中的采用.